Calumet Specialty Products Partners (Nasdaq: CLMT) reported earnings on Oct. 31. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Calumet Specialty Products Partners crushed expectations on revenues and crushed expectations on earnings per share.

Compared to the prior-year quarter, revenue increased significantly and GAAP earnings per share grew significantly.

Margins grew across the board.

Revenue details
 Calumet Specialty Products Partners chalked up revenue of $1.18 billion. The three analysts polled by S&P Capital IQ expected to see a top line of $941.3 million on the same basis. GAAP reported sales were 52% higher than the prior-year quarter's $777.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.07. The five earnings estimates compiled by S&P Capital IQ anticipated $0.64 per share. GAAP EPS of $0.69 for Q3 were 50% higher than the prior-year quarter's $0.46 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 13.4%, 100 basis points better than the prior-year quarter. Operating margin was 5.6%, 120 basis points better than the prior-year quarter. Net margin was 3.6%, 110 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $904.9 million. On the bottom line, the average EPS estimate is $0.57.

Next year's average estimate for revenue is $4.13 billion. The average EPS estimate is $3.23.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 433 members out of 461 rating the stock outperform, and 28 members rating it underperform. Among 145 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 138 give Calumet Specialty Products Partners a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Calumet Specialty Products Partners is hold, with an average price target of $30.75.

Are you missing a major story in the energy space? Read about "One Stock to Own Before Nat Gas Act 2011 Becomes Law." Click here for instant access to this free report.